None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Age between 19 and 75 years at the time of obtaining written informed consent - Patients diagnosed with achalasia who are scheduled to undergo Peroral endoscopic myotomy or have undergone Peroral endoscopic myotomy within the past 7 days - Able to understand and comply with instructions and participate for the entire duration of the clinical trial - Voluntarily decide to participate and provide written informed consent to the clinical trial - For participants of childbearing potential, agreement to use medically appropriate contraception throughout the study period
Exclusion criteria
Exclusion criteria: - Inability to undergo upper gastrointestinal endoscopy - Presence of esophageal stricture, ulcer stricture, esophagogastric varices, Barrett’s esophagus exceeding 3 cm (long-segment Barrett’s esophagus), active peptic ulcer, gastrointestinal bleeding, malignancy, or eosinophilic esophagitis as confirmed by upper gastrointestinal endoscopy - History of surgical procedures involving the esophagus, stomach, or duodenum (except for simple perforation repair or endoscopic tumor resection) - History of hypersensitivity to antacids, proton pump inhibitors, or potassium competitive acid blockers - Current psychiatric disorder under treatment with medication - History of psychiatric disease within the past 5 years - Pregnant or breastfeeding women - Patients scheduled to undergo surgery requiring hospitalization within 3 months of trial participation or requiring surgical treatment - Any other clinically significant findings deemed by the investigator to make the participant inappropriate for this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of esophagitis of LA grade B or higher at 8 weeks after Peroral endoscopic myotomy in each group | — |
Secondary
| Measure | Time frame |
|---|---|
| A difference in treatment response (Reflux Disease Questionnaire score) between groups at 4 and 8 weeks;The presence of inspiratory augmentation on high-resolution manometry performed at 8 weeks in each group | — |
Countries
Korea, Republic of
Contacts
Yonsei University Yongin Severance Hospital